Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study.
Front Pediatr. 2023 Oct 2;11:1260296. doi: 10.3389/fped.2023.1260296. eCollection 2023.
Front Pediatr. 2023.
PMID: 37849499
Free PMC article.
Cite
Cite